Beyond Technology
Where is your vision headed?
Imagine the moment when your diagnostic
solution reaches patients across the globe.
Seegene Technology designs that journey together with every NewCo.
Seegene Technology designs that journey together with every NewCo.
The world continues
to face new and
unpredictable diseases.
Our journey began the moment we
recognized
the limitation of releasing only a handful of products each year
leaving nations unprepared for emerging threats.
We chose to break that mold.
Through syndromic PCR and our Technology-Sharing model,
we enable the simultaneous development and launch of hundreds of assays worldwide.
the limitation of releasing only a handful of products each year
leaving nations unprepared for emerging threats.
We chose to break that mold.
Through syndromic PCR and our Technology-Sharing model,
we enable the simultaneous development and launch of hundreds of assays worldwide.
The Journey Toward Global Dianostic
Sovereignty
With this model, every society can secure
its own health sovereignty through
molecular diagnostics.
With this model, every society can secure
its own health sovereignty through
molecular diagnostics.
It is not merely a transfer of
technology,
but the creation of a
global network
that eliminates diagnostic gaps.
Already, with over 20 years of expertise,
202 products launched,
1,249 regulatory approvals, and presence in 101 countries,
we are ready to take this journey with you.
1,249 regulatory approvals, and presence in 101 countries,
we are ready to take this journey with you.
AI-Powered
Transformation:
From Partner to Pioneer
Seegene’s Technology-Sharing Initiative is
redefining how diagnostics are developed and
delivered worldwide.
By creating NewCos in each country, we empower local partners with our unmatched proprietary syndromic PCR technology enhanced by over 20 years of expertise, unique automation, and know-how transforming them into independent innovators.
By creating NewCos in each country, we empower local partners with our unmatched proprietary syndromic PCR technology enhanced by over 20 years of expertise, unique automation, and know-how transforming them into independent innovators.
See the Technology Behind it →
Strategic Alliances that
Make It Real
We are already working with global
leaders such as Microsoft and Springer
Nature,
actively advancing joint product
development and proof-of-concept
projects.
These partnerships accelerate every
NewCo’s path from development and
regulatory approval to
commercialization.
Jun 15, 2023
Commercialization of Expertise &
Innovation in All Fields
Establish a new business model
empowering researchers to go
beyond mere publications, to
transfer their expertise and
research to developing
commercialized products.
Jan 23, 2024
Reaching the Pinnacle in
Automated Development Technology
Establish an AI-powerd automated
development process utilizing
experts, scientists, and
corporation networks throughout,
from project generation to
product development planning
phases.
Expanding
the Global NewCo
Network
A NewCo is not just a customer.
It is a pioneer eshaping diagnostics under its own name and brand.
Seegene provides full-package support across the value chain development, regulatory, manufacturing, and sales.
And the possibilities are limitless: from infectious diseases, cancer, and genetic disorders to food safety, environmental health, and research.
It is a pioneer eshaping diagnostics under its own name and brand.
Seegene provides full-package support across the value chain development, regulatory, manufacturing, and sales.
And the possibilities are limitless: from infectious diseases, cancer, and genetic disorders to food safety, environmental health, and research.
Localization
Independent market entry of NewCos under their own brands
Independent market entry of NewCos under their own brands
Globalization
Maximizing product diversity and speed to market through a global consortium
Maximizing product diversity and speed to market through a global consortium
Expansion
Expanding PCR applications across all sectors — human, veterinary, agriculture, food, environmental, and biological research
Expanding PCR applications across all sectors — human, veterinary, agriculture, food, environmental, and biological research
From Vision to Reality: NewCo in
Action
From Spain to Israel, NewCo are redefining
access to diagnostics in their
regions.
Israel
Leading the way with Seegene’s first
Technology-Sharing model —
delivering tailored diagnostics for
Israel through the power of multiplex PCR.
Spain
The gateway to Europe, expanding
Seegene’s Technology-Sharing
vision from local markets
to a continent-wide scale.
Unique Technology
Meets Exponential Scalability
The global MDx market is worth over USD 30
billion annually,
and the NewCo model accelerates its growth in both speed and scale.
Seegene Technology grows as NewCos grow.
With every NewCo added to the network,
PCR accessibility expands exponentially across the world.
and the NewCo model accelerates its growth in both speed and scale.
Seegene Technology grows as NewCos grow.
With every NewCo added to the network,
PCR accessibility expands exponentially across the world.